Helios provides specialized compounding services for controlled substances across a vital range of therapeutic areas, focusing on patient-specific preparations where clinically appropriate. This unique approach allows for tailored solutions that address individual patient needs, which may not be met by commercially available medications. Our extensive compounding portfolio covers four critical areas, ensuring comprehensive support for complex conditions. For Pain & Palliative Care, Helios compounds medications like morphine, ketamine, and tramadol, offering customized strengths and dosage forms to optimize pain management and enhance patient comfort. In Psychiatry & Neurology, our expertise extends to patient-specific preparations of drugs such as lorazepam, clonazepam, diazepam, and clobazam, crucial for managing various neurological and mental health conditions with precision. Furthermore, Helios supports individuals with ADHD & Neurodevelopmental disorders by compounding medications like methylphenidate, dextroamphetamine, and lisdexamfetamine, providing custom titration strengths and alternative forms to improve treatment adherence and efficacy. Lastly, our Hormone Therapy compounding includes testosterone and prasterone (DHEA), formulated to precise specifications for personalized hormone replacement therapies. This commitment to patient-specific compounding underscores Helios's dedication to delivering high-quality, customized pharmaceutical solutions that significantly impact patient well-being.